Gene: C20orf96
Official Full Name: chromosome 20 open reading frame 96provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25561 | C20orf96 Knockout cell line (HCT 116) | Human | C20orf96 | 1:2~1:4 | Negative | Online Inquiry |
KO25562 | C20orf96 Knockout cell line (HEK293) | Human | C20orf96 | 1:3~1:6 | Negative | Online Inquiry |
KO25563 | C20orf96 Knockout cell line (A549) | Human | C20orf96 | 1:3~1:4 | Negative | Online Inquiry |
C20orf96 Gene Knockout Cell Lines are specifically engineered cellular models designed to facilitate the study of the C20orf96 gene's function and its implications in various biological processes. This product incorporates advanced genome editing technology, utilizing CRISPR-Cas9 methodology to create precise deletions within the C20orf96 locus. By generating a knockout model, researchers can investigate the gene's role in cellular mechanisms, signaling pathways, and disease states, enhancing our understanding of its biological significance.
The primary function of these cell lines lies in their ability to permit in-depth analysis of C20orf96's loss-of-function effects on cellular biology. The knockout mechanism disrupts normal gene expression, allowing researchers to observe phenotypic changes that arise from this genetic alteration. Consequently, this product becomes vital in uncovering novel pathways involved in cell proliferation, differentiation, and apoptosis that may relate to human diseases, including cancers and genetic disorders.
The utility of C20orf96 Gene Knockout Cell Lines extends to both research and clinical applications. In a research context, these cell lines provide a robust platform for drug discovery, toxicology studies, and translational medicine. Clinically, understanding the functional attributes of the C20orf96 gene may pave the way for potential therapeutic strategies aimed at diseases linked to its dysregulation.
Compared to conventional models, such as wild-type cell lines or transient knockdown systems, the C20orf96 Gene Knockout Cell Lines offer enhanced stability and reproducibility of results, ensuring that experimental outcomes are consistent and reliable over time. This is particularly advantageous for long-term studies and high-throughput screening applications.
For researchers and clinicians alike, the relevance of C20orf96 in various disease pathways coupled with the rigorous validation of these knockout models underscores their significance as a research tool. Our company, with its commitment to advancing genetic research and providing high-quality cellular products, offers C20orf96 Gene Knockout Cell Lines as part of our broader portfolio, ensuring that scientists have access to cutting-edge resources tailored to meet the demands of modern biomedical research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.